17 Nov 08 Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent Chemotherapy
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
(more…)
Tags: Anderson Cancer Center, Bone Cancer, Bone Marrow Toxicity, Cancer Chemotherapy, Cancer Therapy, Cell Lung Cancer, Chemotherapy, Chemotherapy Patients, Imrt, Instances, Intensity Modulated Radiation, Lung Cancer, M D Anderson, M D Anderson Cancer Center, Non Small Cell Lung Cancer, Proton Beam Therapy, Proton Therapy, Small Cell Lung Cancer, University Of Texas, University Of Texas M D Anderson Cancer Center
11 Nov 08 Tumors Grow Faster Without Blood-Supply Promoting Molecule
Dense networks of blood vessels thought to spur cancer’s growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego. The findings partly explain why drugs designed to treat cancer by strangling its blood supply have been disappointing when used alone and why those treatments are more effective when combined with traditional chemotherapy.
(more…)
Tags: Blood Supply, Blood Vessels, California San Diego, Cancer, Chemotherapy, Drugs, Molecule, Traditional Chemotherapy, Tumor Progression, Tumors, University Of California, University Of California San Diego
11 Nov 08 Tumors Grow Faster Without Blood-Supply Promoting Molecule
Dense networks of blood vessels thought to spur cancer’s growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego. The findings partly explain why drugs designed to treat cancer by strangling its blood supply have been disappointing when used alone and why those treatments are more effective when combined with traditional chemotherapy.
(more…)
Tags: Blood Supply, Blood Vessels, California San Diego, Chemotherapy, Traditional Chemotherapy, Tumor Progression, University Of California San Diego
09 Nov 08 Study Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a global Phase III study (SATURN) met its primary endpoint and showed Tarceva® (erlotinib) significantly extended the time patients with advanced non-small cell lung cancer (NSCLC) lived without their cancer getting worse when given immediately following initial treatment with platinum-based chemotherapy, compared to placebo.
(more…)
Tags: Cell Lung Cancer, Chemotherapy, Endpoint, Erlotinib, Free Survival, Genentech Inc, Global Phase, Initial Treatment, Line Maintenance, Lung Cancer, Maintenance Therapy, Nasdaq, Non Small Cell Lung Cancer, Nyse, Osi Pharmaceuticals Inc, Phase Iii, Small Cell Lung Cancer, Study Saturn, Tarceva, Time Patients
09 Nov 08 Researchers Find Predictive Tests And Early Treatment Delay Progression Of Blood Cell Cancer
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia (CLL). Their study, published Oct.
(more…)
Tags: Biomarkers, Blood Cancer, Blood Cell, Cancer Clinic, Cell Cancer, Chemotherapy, Chronic Lymphoid Leukemia, Conventional Chemotherapy, Delay Progression, Leukemia, Mayo Clinic Researchers, Personalized Care, Predictive Tests
09 Nov 08 Researchers Find Predictive Tests And Early Treatment Delay Progression Of Blood Cell Cancer
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia (CLL). Their study, published Oct.
(more…)
Tags: Biomarkers, Blood Cancer, Blood Cell, Cancer Clinic, Cell Cancer, Chemotherapy, Chronic Lymphoid Leukemia, Conventional Chemotherapy, Delay Progression, Leukemia, Mayo Clinic Researchers, Personalized Care, Predictive Tests
09 Nov 08 Accelr8 Announces Study Results With Rapid ESBL Test For Broad Resistance In Gram-Negative Pathogens
Accelr8 Technology Corporation (Amex: AXK) announced study results today that were presented at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA), October 25-29 in Washington, DC.
(more…)
Tags: Amex, Annual Interscience Conference, Antimicrobial Agents, Axk, Chemotherapy, Icaac, Idsa, Infectious Diseases, Infectious Diseases Society, Infectious Diseases Society Of America, Pathogens, Resistance, Sessions, Technology Corporation, Washington Dc
06 Nov 08 MIT Creates Tiny Backpacks For Cells - Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis
MIT engineers have outfitted cells with tiny “backpacks” that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering. Michael Rubner, director of MIT’s Center for Materials Science and Engineering and senior author of a paper on the work that appeared online in Nano Letters on Nov. 5, said he believes this is the first time anyone has attached such a synthetic patch to a cell.
(more…)
Tags: Backpacks, Building Blocks, Cancer Diagnosis, Cells, Chemotherapy, Chemotherapy Agents, Drugs, Materials Science And Engineering, Mit, Nano Letters, Nov 5, Patches, Polymer, Rubner, S Center, Synthetic Patch, Tissue Engineering, Tumors
06 Nov 08 MIT Creates Tiny Backpacks For Cells - Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis
MIT engineers have outfitted cells with tiny “backpacks” that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering. Michael Rubner, director of MIT’s Center for Materials Science and Engineering and senior author of a paper on the work that appeared online in Nano Letters on Nov. 5, said he believes this is the first time anyone has attached such a synthetic patch to a cell.
(more…)
Tags: Backpacks, Building Blocks, Cancer Diagnosis, Cells, Chemotherapy, Chemotherapy Agents, Drugs, Materials Science And Engineering, Mit, Nano Letters, Nov 5, Patches, Polymer, Rubner, S Center, Synthetic Patch, Tissue Engineering, Tumors
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
05 Nov 08 BPA exposure linked to chemotherapy resistance (Reuters)
Reuters - Exposure to bisphenol A (BPA) — a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans — may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.
(more…)
Tags: Bpa, Chemotherapy, Chemotherapy Treatments, Environmental Health Perspectives, Food Cans, Resistance, Reuters, Scientists
20 Oct 08 Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma (HealthDay)
HealthDay - MONDAY, Oct. 20 (HealthDay News) — The risk of death for someone
with non-Hodgkin lymphoma increases if one is poor but decreases if the
person receives chemotherapy, a new study shows.
(more…)
Tags: Chemotherapy, Healthday, Lymphoma, Mortality Risk, Non Hodgkin Lymphoma, Poverty
20 Oct 08 Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma (HealthDay)
HealthDay - MONDAY, Oct. 20 (HealthDay News) — The risk of death for someone
with non-Hodgkin lymphoma increases if one is poor but decreases if the
person receives chemotherapy, a new study shows.
(more…)
Tags: Chemotherapy, Healthday, Lymphoma, Mortality Risk, Non Hodgkin Lymphoma, Poverty
20 Oct 08 Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma (HealthDay)
HealthDay - MONDAY, Oct. 20 (HealthDay News) — The risk of death for someone
with non-Hodgkin lymphoma increases if one is poor but decreases if the
person receives chemotherapy, a new study shows.
(more…)
Tags: Chemotherapy, Healthday, Lymphoma, Mortality Risk, Non Hodgkin Lymphoma, Poverty
20 Oct 08 Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma (HealthDay)
HealthDay - MONDAY, Oct. 20 (HealthDay News) — The risk of death for someone
with non-Hodgkin lymphoma increases if one is poor but decreases if the
person receives chemotherapy, a new study shows.
(more…)
Tags: Chemotherapy, Healthday, Lymphoma, Mortality Risk, Non Hodgkin Lymphoma, Poverty
20 Oct 08 Computer Model Reveals Cells’ Inner Workings - MIT
After spending years developing a computational model to help illuminate cell signaling pathways, a team of MIT researchers decided to see what would happen if they “broke” the model. The results, reported in the Oct. 17 issue of the journal Cell, reveal new ways in which cells process chemical information and could indicate how to maximize the effectiveness of disease treatments such as chemotherapy.
(more…)
Tags: Cell Signaling Pathways, Cells, Chemical Information, Chemotherapy, Computational Model, Computer Model, Inner Workings, Mit, New Ways
